Posted on:
Tuesday, October 6th 2020 at 10:15 am
.jpg)
Originally published on www.thevaccinereaction.org
If you look at the human clinical trials that have been conducted this year by drug companies developing experimental vaccines for COVID-19, the participants in those trials have all been "healthy adults." Take, for example, Moderna's Phase 1 clinical trial for its mRNA-1273 vaccine, which included 45 healthy adults 18 to 55 years old. The same is true for the Phase 1/2 clinical trial for the BNT162b1 vaccine being developed jointly by Pfizer and BioNTech. That trial also involved 45 healthy adults between the ages of 18 and 55 years.1 2 3 4 5 6
The Phase 1 clinical trial for CanSino Biologics' Ad5-nCoV vaccine included 108 healthy adults 45 to